Ambu Full Year 2022 Earnings: Revenues In Line With Expectations

Ambu (CPH:AMBU B) Full Year 2022 Results

Key Financial Results

• Revenue: kr.4.44b (up 11% from FY 2021).
• Net income: kr.93.0m (down 62% from FY 2021).
• Profit margin: 2.1% (down from 6.2% in FY 2021).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Ambu Meets Expectations

Revenue was in line with analyst estimates.

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 8.0% growth forecast for the Medical Equipment industry in Denmark.

Performance of the Danish Medical Equipment industry.

The company's shares are down 18% from a week ago.

Risk Analysis

It is worth noting though that we have found 3 warning signs for Ambu that you need to take into consideration.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.